FLNA
Filana Therapeutics, Inc.
There isn't enough reported data to score FLNA yet.
FLNA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
FLNA's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
FLNA PE Valuation
FLNA has no meaningful PE right now: it lost money over the past year.
FLNA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect FLNA's losses to grow, with revenue holding steady.
FLNA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.87 | +$1.33 |
| Q2 2026 | -$0.87 | +$1.69 |
| Q1 2026 | -$1.61 | -$0.10 |
| Q4 2025 | -$1.88 | -$0.42 |
| Q3 2025 | -$2.20 | -$0.82 |
| Q2 2025 | -$2.56 | -$1.15 |
| Q1 2025 | -$1.51 | +$0.66 |
| Q4 2024 | -$1.46 | +$0.86 |
FLNA is still losing money, but far less than before: $0.87 per share over the past year, against $2.56 at its worst in mid-2025.
FLNA Quarterly Revenue
FLNA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.1M | +$176K |
| Q1 2026 | -$8.9M | +$2.5M |
| Q4 2025 | -$10.2M | +$51.1M |
| Q3 2025 | -$6.3M | +$12M |
| Q2 2025 | -$4.9M | +$13.3M |
| Q1 2025 | -$11.3M | +$7.8M |
| Q4 2024 | -$61.3M | -$39M |
| Q3 2024 | -$18.3M | +$8.2M |
FLNA has burned cash in almost every quarter: −$32M over the past year, against −$96M the year before.
FLNA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.1% | +2M shares |
| 1 year | +4.1% | +2M shares |
| 3 years | +20% | +8.3M shares |
| 5 years | +26% | +10.3M shares |
| Available history | +105% | +25.8M shares |
FLNA has 50M diluted shares, up 4.1% from a year ago.
FLNA Net Leverage
FLNA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FLNA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.4 | Oversold |
| Stochastic | 2.9 | Oversold |
FLNA's weekly RSI is 27 (oversold) and its Stochastic is 3 (oversold).
FLNA PE vs Healthcare Sector
FLNA has no meaningful PE right now: it lost money over the past year.
FLNA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.67 | 33% below |
| 20 week MA | $0.84 | 46% below |
| 50 week MA | $1.45 | 69% below |
| 100 week MA | $1.93 | 77% below |
| 200 week MA | $12.1 | 96% below |
FLNA is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
FLNA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.21 | $7.49 | +44% |
| 2021 | $7.49 | $44.2 | +490% |
| 2022 | $44.2 | $31.7 | -28% |
| 2023 | $31.7 | $22.5 | -29% |
| 2024 | $22.5 | $2.50 | -89% |
| 2025 | $2.50 | $2.18 | -13% |
| 2026 YTD | $2.18 | $0.45 | -79% |
FLNA has finished four years in a row lower, and it's down 79% so far in 2026.